EVERYTHING ABOUT RAW MATERIALS

“The existing problem has exposed some structural weaknesses inside the EU’s medicines source chain along with a substantial dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides mentioned. She suggested that offer chain challenges be addressed in an EU pharmaceutical method predicted being launched by the end of the